{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:22:08Z","timestamp":1780676528290,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":3123,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1074\/jbc.m111.305417","type":"journal-article","created":{"date-parts":[[2011,12,21]],"date-time":"2011-12-21T01:50:15Z","timestamp":1324432215000},"page":"9982-9989","source":"Crossref","is-referenced-by-count":27,"title":["Protein Misfolding Detected Early in Pathogenesis of Transgenic Mouse Model of Huntington Disease Using Amyloid Seeding Assay"],"prefix":"10.1016","volume":"287","author":[{"given":"Sharad","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shy'Ann","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.305417_bib1","first-page":"317","article-title":"On chorea","volume":"26","author":"Huntington","year":"1872","journal-title":"Med. Surg. Rep."},{"key":"10.1074\/jbc.M111.305417_bib2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.305417_bib3","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M111.305417_bib4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00001756-199806010-00028","article-title":"Neuronal distribution of intranuclear inclusions in Huntington disease with adult onset","volume":"9","author":"Gourfinkel-An","year":"1998","journal-title":"Neuroreport"},{"key":"10.1074\/jbc.M111.305417_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","article-title":"Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains","volume":"68","author":"Herndon","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.M111.305417_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1750-3639.2006.00040.x","article-title":"Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington disease","volume":"17","author":"Maat-Schieman","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1074\/jbc.M111.305417_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/exnr.1998.7005","article-title":"Huntington disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein","volume":"156","author":"Sieradzan","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1074\/jbc.M111.305417_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis, but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.305417_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.305417_bib10","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","article-title":"Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells","volume":"11","author":"Yang","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nchembio.283","article-title":"A causative link between the structure of aberrant protein oligomers and their toxicity","volume":"6","author":"Campioni","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.M111.305417_bib12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.M111.305417_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.305417_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.305417_bib15","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.305417_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2008.02.010","article-title":"Beneficial effects of rolipram in the R6\/2 mouse model of Huntington disease","volume":"30","author":"DeMarch","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib17","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.305417_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/hmg\/8.7.1227","article-title":"Ultrastructural localization and progressive formation of neuropil aggregates in Huntington disease transgenic mice","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nbd.2010.10.015","article-title":"Brief ampakine treatments slow the progression of Huntington disease phenotypes in R6\/2 mice","volume":"41","author":"Simmons","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib22","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.305417_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","article-title":"Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington disease","volume":"118","author":"Z\u00e1dori","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1074\/jbc.M111.305417_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.305417_bib26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib27","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.305417_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.305417_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib30","doi-asserted-by":"crossref","first-page":"20914","DOI":"10.1073\/pnas.0710152105","article-title":"Prion detection by an amyloid seeding assay","volume":"104","author":"Colby","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.305417_bib31","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/bi1013744","article-title":"A kinetic aggregation assay allowing selective and sensitive amyloid-\u03b2 quantification in cells and tissues","volume":"50","author":"Du","year":"2011","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M111.305417_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/ajcp\/47.5.588","article-title":"Thioflavin T for amyloid detection","volume":"47","author":"Saeed","year":"1967","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1074\/jbc.M111.305417_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","author":"Wilham","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.M111.305417_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M111.305417_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000736","article-title":"Protease-sensitive synthetic prions","author":"Colby","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1074\/jbc.M111.305417_bib36","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1073\/pnas.0812083106","article-title":"Distinct conformations of in vitro and in vivo amyloids of huntingtin exon 1 show different cytotoxicity","volume":"106","author":"Nekooki-Machida","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.305417_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0076-6879(06)13003-7","article-title":"Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay","volume":"413","author":"O'Nuallain","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1074\/jbc.M111.305417_bib38","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1523\/JNEUROSCI.2365-04.2004","article-title":"Biochemical, ultrastructural, and reversibility studies on huntingtin filaments isolated from mouse and human brain","volume":"24","author":"D\u00edaz-Hern\u00e1ndez","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.305417_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","article-title":"Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity","volume":"311","author":"Chen","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.M111.305417_bib40","doi-asserted-by":"crossref","first-page":"11884","DOI":"10.1073\/pnas.182276099","article-title":"Huntington disease age of onset linked to polyglutamine aggregation nucleation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.305417_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)80514-0","article-title":"Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo","volume":"90","author":"Scherzinger","year":"1997","journal-title":"Cell"},{"key":"10.1074\/jbc.M111.305417_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1006\/nbdi.2001.0385","article-title":"Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA","volume":"8","author":"Schilling","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.305417_bib43","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1074\/jbc.M111.305417_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1074\/jbc.M111.305417_bib46","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1074\/jbc.M109.093708","article-title":"Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo","volume":"285","author":"Legleiter","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.305417_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio792","article-title":"Stochastic kinetics of intracellular huntingtin aggregate formation","volume":"2","author":"Colby","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.M111.305417_bib48","doi-asserted-by":"crossref","first-page":"17616","DOI":"10.1073\/pnas.0408134101","article-title":"Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody","volume":"101","author":"Colby","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820654114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820654114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.305417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T08:49:30Z","timestamp":1641372570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820654114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0021925820654114"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.305417","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}